European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience
.
Main Authors: | A. T. van der Ploeg, M. Ую Kruijshaar, A. Toscano, P. Laforet, C. Angelini, R. H. Lachmann, S. I. Pascual Pascual, M. Roberts, K. Rosler, T. Stulnig, P. A. van Doorn, P.Y. K. Van den Bergh, J. Vissing, B. Schoser |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2019-01-01
|
Series: | Нервно-мышечные болезни |
Subjects: | |
Online Access: | https://nmb.abvpress.ru/jour/article/view/301 |
Similar Items
-
Social-economic burden of Pompe disease with late onset in the Russian Federation
by: A. S. Kolbin, et al.
Published: (2019-04-01) -
Late-onset Pompe disease: preliminary results of enzyme replacement therapy
by: L. P. Smertina, et al.
Published: (2019-07-01) -
Pompe disease and ophthalmopathy: literature review
by: Tuy Nga Brignol, et al.
Published: (2015-05-01) -
Infantile Pompe disease: Clinical picture, diagnosis, and treatment
by: N. P. Kotlukova, et al.
Published: (2015-02-01) -
Alpha-mannosidosis in children: analysis of the observations and treatment options
by: A. N. Semyachkina, et al.
Published: (2020-09-01)